the herpesvirus dna polymerase inhibitor foscarnet , applied topically , and the anti-herpesvirus guanosine analogue buciclovir , given orally , decreased virus replication and disease development in primary skin infections of mice caused by herpes simplex virus type 1 ( hsv-1 ) .
C0070895
foscarnet
C1371554
decreased